|
Breast Cancer LectureDr. Clarence PetrieApril 12, 2000A breast is a modified sweat gland"Milk Ridge" – Two imaginary lines, one drawn from each shoulder down to the sides of the groin, in which breast tissue may be found. The outer upper quadrant of the breast is where the majority of cancers are found. Ductal Cancer – 85% of all breast cancers. Found in milk ducts. Lobular Cancer – 15% of all breast cancers. Found in lobes of breasts. Breast Cancer is primarily spread through lymphatic drainage. BREAST CANCER: -Cause is unknown -No definitive prevention measure other than new anti-hormone therapy with the drug Tamoxifen -Progressive disease -Survival increases with early detection and treatment: early stage 96% late stage 20% -In 1974, 1/15 women were diagnosed with breast cancer. In 2000, 1/8 woman will be diagnosed with breast cancer. -Leading cause of cancer mortality in women ages 40 – 55
RISK FACTORS: -Gender. 1/8 women, 1/100 men are diagnosed with breast cancer. -Age. Risk increases with age. -Personal family history. -Nulliparous. Women who have never been pregnant have a greater risk factor. -Onset and cessation of menses. -Obesity note: 75% of women with breast cancer have no identifiable risk factors. -15% of breast cancers are familial; 45% are linked to the gene BRCA1, 45% are linked to BRCA2, and 10% are undefined. FACTORS THAT SUGGEST THE POSSIBLE PRESENCE OF GENETIC PREDISPOSITION FOR BREAST CANCER: -Involvement of multiple generations -Involvement of multiple first degree relatives (Mom, Dad, Sister, Brother) -Premenopausal breast cancer -Bilateral breast cancer (cancer in both breasts) -Presence of ovarian cancer ESTROGEN REPLACEMENT THERAPY: -A slightly increased incidence of cancer when all studies are considered -Will increase the growth rate of an existing cancer -Benefits (ie, prevention of osteoporosis) outweigh the risks
PROGNOSTIC FACTORS: -Size and spread of primary tumor -Presence or absence of axillary nodal involvement (most important factor) -Presence or absence of estrogen receptors in the tumor AXILLARY NODAL INVOLVEMENT: -Most tumors under 1 cm do not have positive nodes -50% of all patients with tumors of 2 cm have positive nodes 3 STEPS TO EARLY DETECTION:
MAMMOGRAPHY: -Begin at age 40 -Detects 90% of all 1 cm breast cancers -Compared with old mammography films to detect new suspicious growths ULTRASOUND: -Differentiates cysts from cancers. Cysts show up on ultrasounds as clear black spots; cancerous tumors will show up as a gray/white area. -Finds cancers that may not show up on mammograms EFFECT OF MAMMOGRAPHY ON BREAST CANCER OUTCOME: -Women whose lesions are detected by mammography alone have better survival -Routine screening mammography in women ages 50-60 results in 30% reduction in mortality -Women ages 40-49 who undergo routine screening when followed more than 10 years show an increase in survival LOBULAR CARCINOMA IN SITU: -Risk of breast cancer for rest of life is 60% -Does not tell you where cancer may occur next – ie, may be bilateral or in ducts Options: 1) Observe 2) Bilateral simple mastectomy DUCTAL CARCINOMA IN SITU: Options: 1) Simple mastectomy 2) Excision and RT (radiotherapy – 6 weeks, 5 days a week) 3) Excision alone INVASIVE CANCER, STAGES I & II: Options: 1) Mastectomy 2) Mastectomy with reconstruction 3) Lumpectomy with axillary node dissection and RT – 60% are treated this way INVASIVE CANCER, STAGE IIIA:
INVASIVE CANCER, STAGE IIIB: -"Inflammatory histology" -Survival rate 20% -Induction chemotherapy followed by mastectomy and/or RT
NEW DEVELOPMENTS: -Pacific Yew tree – the leaves from this tree are used in manufacturing the chemotherapy drug Taxol. It is one of the most efficient chemotherapy agents for breast and ovarian cancers. -In order to spare any possible axillary nodes, doctors are injecting the breast with radioactive material and blue dye around the tumor site. They then trace the path to which lymph nodes are affected by the cancer and remove those only. This helps the lessen effects of lymphedema. |
Last modified: March 25, 2001 01:45 PM
|